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Abstract 
Setting: Supportive living and assisted living memory care facilities in a rural West-Central Illinois county. 
Objectives: 1) Evaluate the impact of active pharmacist participation on patient care for residents living in supportive and assisted 
living facilities, 2) demonstrate feasibility and financial sustainability of rural community pharmacists providing disease state 
management services, 3) create processes for best practice to expand the clinical role of the community pharmacist 
Design: Case study.  
Interventions: Participating residents received disease state management services provided by a community pharmacist as outlined 
through collaborative practice agreements with local physicians. The disease states managed included hypertension, hyperlipidemia, 
diabetes mellitus, and warfarin anticoagulation therapy. The pharmacist completed an initial chart review, initial face-to-face visit, 
subsequent monthly chart reviews, and monthly face-to-face visits with each resident. 
Results: During the 6-month period of community pharmacist management, 86 face-to-face visits were completed to deliver a median 
of 5 visits per resident. The pharmacist identified 23 drug therapy problems with recommended solutions communicated to the 
resident’s primary care provider. Providers accepted 19 of these recommendations, reflecting an 82.6% acceptance rate.  
Conclusions: Community pharmacists can feasibly implement enhanced clinical services to assist with disease state management of 
supportive living and assisted living residents in collaboration with physicians. Pharmacists can provide clinical assessment, education 
and effective communication to optimize medication management and utilization.  
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Introduction 
The population of persons 65 years of age or older in the 
United States is expected to reach 83.7 million people by the 
year 2050. This is due to aging of the baby boomer generation 
and increasing life expectancy.1 As people age they are at 
higher risk of developing chronic disease, having multiple 
medications to treat the chronic disease, and needing 
advanced levels of coordinated care to maintain functionality.2 
In addition to medication concerns, physical and cognitive 
impairments lead to varying levels of functionality of which 
some people can manage in their own home while others 
require various levels of skilled care associated with assisted 
living facilities (ALF) or long-term skilled nursing facilities. 
Assisted living facilities are viewed as a more residential-like 
and less institutionalized setting that does not have an overly 
regulated, inflexible environment as compared with a nursing 
home.3 Regulation and licensure for ALFs differs in rigidity and 
depth from state to state while skilled nursing home facilities 
are largely regulated at the federal level through Centers for 
Medicare and Medicaid Services (CMS).3 
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Residential care/assisted living facilities were rapidly growing 
in the United States in the early 2000s as an alternative to long-
term skilled nursing facilities, to create an opportunity for 
higher functioning older adults to retain a level of 
independence. For less frail older adults, ALFs are a more 
appropriate level of care and use of resources.3 Consultant 
pharmacists have had a regulatory presence in the long-term 
skilled nursing setting as mandated by CMS performing drug 
regimen reviews (DRR) for each resident at least once a month, 
evaluating for unnecessary drugs, and assisting with the 
development and implementation of a care plan for each 
resident within 48 hours of admission; among other tasks.4 
Assisted living facilities have not had this mandatory 
pharmacist oversight.  
 
In 1991, the Beers Criteria outlining potentially inappropriate 
medication use in older adults was published and an emphasis 
to change medication regimens in persons 65 years of age and 
older to a safer or more effective alternative began.5 Research 
from the early 2000s reported a propensity to undertreat 
conditions and under prescribe medications to residents living 
in assisted living facilities in order to preserve independence 
and limit prescription overuse, adverse drug events, and drug-
drug interactions.6 However in the last decade, research 
regarding residential care/assisted living has been lacking. The 
research available states the primary interventions are de-
prescribing of potentially inappropriate medications and 
medication management.6 The lack of information of 
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pharmacists’ impact on helping patients achieve therapeutic 
goals through collaborative practice agreements with rural 
physicians to perform disease state management in the 
assisted living and supportive living settings is the rationale for 
this project. 
 
The beneficial involvement and accessibility of pharmacists as 
a member of the interdisciplinary healthcare team has been 
well documented in several settings including health systems 
and ambulatory care clinics.7-8 However, the adoption of 
clinically focused outpatient pharmacy services among the 
aging population within community settings has been much 
slower.  Access to healthcare in rural areas for persons living in 
supportive living or assisted living facilities is suboptimal due 
to physician shortages and a relative lack of geriatric services.9-
10 Literature suggests independence and quality of life, among 
other factors, have a positive correlation with the subjective 
perception of wellbeing among the aging.11 Adding the most 
accessible healthcare professional, a pharmacist, working in 
concert with the healthcare team to provide comprehensive 
reviews on medications and treatment care plans, can 
empower the aging patient to take responsible control of his 
or her health status.7 This in turn may allow the patient to 
remain at home or in a home-like setting (i.e., supportive living 
or assisted living facility) longer.  
 
Pharmacists receive extensive training throughout their 
clinical curriculum to become effective communicators to both 
physicians and licensed nursing staff through the use of 
relevant clinical language. They also have the ability to counsel 
patients using patient-friendly language and to act as a liaison 
between the patient and healthcare providers. Pharmacists 
have the education and skills to perform disease state 
management services using evidence-based medicine 
published guidelines. This foundation of pharmaceutical care 
is synergistically realized when implemented within a 
collaborative practice agreement with a provider. Because 
rural medically underserved areas have provider shortages 
and limited geriatric services, the freeing up of providers to 
care for more complex conditions or acute health changes by 
pharmacists performing disease state management services is 
monumental. 
 
The geriatric-focused pharmacist uses comprehensive 
medication expertise along with the physiologic knowledge of 
the aging body to help preserve functionality and quality of life 
for the aging person. With this in mind, pharmacist 
involvement may decrease medication related adverse 
reactions, prevent overmedication, lessen the use of 
potentially inappropriate medications, and recommend 
therapeutic alternatives for increased efficacy. Other aspects 
pharmacists can positively impact include enhancing cost 
containment as related to medication utilization, providing 
point-of-care testing, offering interpretation of objective 
results, and assisting with monitoring and follow-through of 
the existing care plan.  
Setting 
This study took place in a rural, socially and politically 
conservative, predominantly white community in a West-
Central Illinois county with a population of 18,500. The county 
is primarily made up of large corn and soybean farms and is 
sparsely populated. The target population for the study 
consisted of a maximum of 62 residents living in Hancock 
Village Senior Services, which is comprised of two supportive 
living facilities (Hickory Grove: North and South) and two 
assisted living memory care facilities (Maple Grove: Red and 
Silver). Hancock Village was consistently 90-95% filled to 
capacity throughout the durations of the study. At the time of 
this study’s initiation (2016), the Hancock Village campus was 
Illinois’s first supportive living and assisted living memory care 
facility, constructed with funding from a grant from the United 
States Department of Agriculture. Hancock Village Senior 
Services is an affiliate of the local health system comprised of 
Memorial Hospital and Memorial Medical Clinics.  
 
Hickory Grove – Supportive Living 
Both Hickory South and Hickory North buildings each house 
approximately 20 residents. Licensed nursing staff is available 
during the day Monday through Friday and universal workers 
are present 24 hours daily in all facilities. A universal worker is 
trained to care for basic hygiene, perform basic housekeeping 
tasks, and provide medication or treatment plan reminders to 
the resident. However, they are not licensed or trained to 
handle medications. The residents living in Hickory Grove must 
be able to administer their own medications, which are kept in 
an accessible location in the apartment.  Residents can either 
choose to manage their medications without assistance (i.e. 
keep medications in vials and take as prescribed) or they may 
request to have universal worker or nursing assistance (i.e. set 
up medications in planners or receive administration 
reminders). 
 
Maple Grove – Assisted Living Memory Care 
Both Red Maple and Silver Maple buildings each house 
approximately 9 residents. Licensed nursing staff is available 
during the day Monday through Friday and universal workers 
are present 24 hours daily in all facilities. The residents residing 
in Maple Grove have varying levels of memory impairment 
which requires routine licensed nursing oversight: such as 
evaluating any changes in health status, communicating 
health-related concerns to physicians, and ensuring resident 
attendance at scheduled physician appointments. Maple 
Grove residents must be able to administer their own 
medications, which are secured in a locked drawer in their own 
apartment. At the appropriate administration time, the 
resident receives a medication reminder by a universal worker 
who unlocks the drawer for the resident to take his or her 
medication. 
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Practice Description 
Gaps in care associated with medication utilization were 
identified at Hancock Village by the registered nurse on the 
research team. These gaps in care were primarily related to 
suboptimal continuity of care or siloed care: residents           
using multiple pharmacies, residents using multiple 
physicians/specialists, residents going 6-12 months in between 
doctor appointments, etc. Two of the major observations were 
delays in warfarin regimen adjustments after INR blood work 
and delays in ordering changes after providers adjusted 
medications at an office visit. When she observed these 
unnecessary delays regarding medication utilization, she 
brought it to the attention of the facility nursing staff and 
community pharmacists to problem solve for more efficient 
options. 
 
Two community pharmacists from Nauvoo Pharmacy used the 
available opportunity for pharmacists’ to actively manage 
medications through collaborative practice agreements as the 
solution to improve continuity of care and provide more 
effective follow-through relating to medication changes. 
Nauvoo Pharmacy is an independent, community pharmacy 
that serves the study area and has the vision to clinically 
integrate with the entire healthcare team. There were two 
community pharmacists, a registered nurse, and a professor of 
pharmacy on the research team. Of the two community 
pharmacists from Nauvoo Pharmacy, one primarily conducted 
the on-site visits with residents and made clinical 
recommendations (“clinical pharmacist”) while the other 
handled the dispensing of medications and logistical needs of 
the project (“dispensing pharmacist”). The registered nurse 
performed the state-mandated quarterly assessments for 
every resident living at Hancock Village, but was not one of the 
facilities’ main staff nurses. The professor of pharmacy 
assisted with study design, data analysis, and interpretation of 
results.  
 
Objectives 
The primary goal of the study was to determine the role and 
impact of community pharmacists’ in performing clinical 
services in the supportive living and assisted living setting by 
assisting rural physicians and nurse practitioners in managing 
disease states through collaborative practice agreements, 
communicating more effectively with nursing staff, and 
empowering patients to achieve therapeutic outcomes in 
accordance with current national guidelines. The study 
objectives were 1) to evaluate the impact of active pharmacist 
participation on patient care for residents in supportive and 
assisted living settings, 2) to demonstrate the feasibility and 
sustainability of rural community pharmacists providing 
disease state management services, and 3) to create processes 
for best practice that can be used to expand the clinical role of 
the community pharmacist within the interdisciplinary team. 
 
 
 
Methods 
Study Design 
The study design of this research was a case study.   
 
Study Population 
The target study population was approximately 60 persons 
residing at Hancock Village diagnosed with one or more of the 
following disease states: hypertension, hyperlipidemia, 
diabetes mellitus, and warfarin anticoagulation therapy. There 
was no inclusion or exclusion data based upon gender, race, or 
age.  
 
Participant Recruitment 
A packet was sent out to each resident, which included a letter 
of explanation of the study, a sample of the compliance 
packaging, and a biography sheet describing the researchers. 
A meeting at Nauvoo Pharmacy was held for the Hancock 
Village licensed nursing staff, collaborating physicians, and 
facility administrators to describe the anticipated workflow, 
demonstrate the new compliance packaging, and answer 
questions. The research nurse and clinical pharmacist 
attended a medical staff meeting at Memorial Medical Clinics 
to inform the entire medical staff of the program, goals, 
benefits, and to answer any questions. The research nurse and 
clinical pharmacist attended a full staff meeting at Hancock 
Village including universal workers, administrators, and other 
staff members to inform them of the new program. Open 
meetings explaining the goals, risks and benefits of the study, 
and answering questions or concerns for interested residents 
and family members were held about two weeks after the 
packets were sent out. These meetings were sparsely attended 
with only 4 study participants signing up. One-on-one 
recruiting was then employed during each resident’s quarterly 
nursing assessment. This method was more successful with 
nine of the study participants gradually recruited over the last 
4 months of the data collection phase. As stated previously, 
the research nurse completed the state-mandated quarterly 
assessments for each resident and continued to mention the 
purpose and benefits of the study and encourage 
participation. 
 
Data Collection 
Collaborative practice agreements (CPAs) were created and 
signed by all three participating rural physicians for 
hypertension, hyperlipidemia, diabetes mellitus and warfarin 
anticoagulation therapy before the data collection period 
began. All CPAs were created in accordance with current 
national guidelines for each disease state as established from 
evidence-based medicine (i.e. JNC 8, AHA/ACC, ADA, 
AACE/ACE, and CHEST) and outlines were adopted from 
Community Health Association of Spokane, Washington 
(CHAS). The CPAs gave the pharmacist the authority to make 
changes to medication therapy including initiation, 
adjustments, and discontinuations. Informed consent was 
obtained from each study participant or the appropriate 
patient representative before data collection began. 
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Participants were managed by the pharmacist for multiple 
conditions covered within the scope of the CPAs. The study 
and all recruitment material were approved by the Drake 
University Institutional Review Board.  
 
Care Model Development 
The clinical community pharmacist was credentialed as a 
Board Certified Geriatric Pharmacist (BCGP). She completed an 
initial chart review to familiarize herself with each resident’s 
past medical history, a current reconciled medication list, most 
recent laboratory results, allergies, current co-morbidities, and 
main health concerns. After the initial chart review, monthly 
chart reviews were performed that focused on changes in 
medications and health status. Each study participant was 
visited face-to-face initially and then monthly, or more often if 
medications were adjusted, to assess adherence, medication 
concerns, and perform objective tests such as blood pressure, 
heart rate, International Normalized Ratio (INR), etc., as 
required for disease state management. The clinical 
pharmacist was granted access to Memorial Medical’s 
electronic medical record to obtain objective data. A read-only 
version of Dispill®, the pharmacy software used for creating 
compliance packaging labels and supplying Medication 
Administration Records (MARs) to the nursing staff, was 
installed on Hancock Village nursing staff computers. This 
provided a real-time medication list for doctor appointments 
or emergency room visits and location for the nursing staff to 
view notes made by the pharmacists about medication 
adjustments. A Clinical Laboratory Improvement Amendments 
(CLIA) waiver was obtained for the purpose of point-of-care 
testing using the CoaguChek® device for residents on warfarin 
anticoagulation therapy. The data collection period spanned 
six months from February 28 to August 31, 2017.  
 
Results 
A total of 15 of the approximate 60 residents residing at 
Hancock Village participated and completed the study. Eleven 
of the participants lived in Hickory Grove (supportive living) 
and four lived in Maple Grove (assisted living). Pharmacist 
interventions were tracked for the four disease states of 
hypertension, hyperlipidemia, diabetes mellitus, and warfarin 
anticoagulation therapy in relation to corresponding CPAs. Of 
the 15 participants, 14 were managed for hypertension, 9 for 
hyperlipidemia, 3 for diabetes mellitus, and 1 for warfarin 
anticoagulation therapy. Residents diagnosed with multiple 
comorbidities, inclusive of the CPAs, were managed for those 
conditions.  
 
During the six-month period of community pharmacist 
management, 86 face-to-face visits were completed. A median 
of 5 visits per resident occurred during the six-month data 
collection phase. [Table 1]  
 
 
 
 
Table 1. 
Month Residents 
Enrolled 
Pharmacist-
Resident Visits 
February 4 4 
March 6 6 
April 6 6 
May 10 12 
June 13 14 
July 14 16 
August 15 28 
Total 15 86 
 
Twenty-three drug therapy problems were identified with 
recommended solutions communicated to the residents’ 
primary care providers. Nineteen of these pharmacist-initiated 
recommendations were accepted by providers, which 
reflected an 82.6% acceptance rate. The breakdown of drug 
therapy problems identified with accepted and rejected 
recommendations is detailed in Appendix A.  
 
Previous pneumococcal (Prevnar13 and Pneumovax) and 
shingles (Zostavax) vaccination history was assessed during the 
initial chart review. Seven Prevnar13 vaccines, 4 Zostavax 
vaccines, and 11 High-Dose Fluzone vaccines were 
administered during the study period. No Pneumovax vaccines 
were administered during this study due to the Centers for 
Disease Control and Prevention (CDC) recommended 12-
month separation period between Prevnar13 and Pneumovax.  
 
Impact on patient care 
The greatest impact of the community pharmacist during this 
study was improved lines of communication with providers, 
nursing staff, and patients and optimization of medication 
regimens in accordance with CPAs. Through repeated 
interactions during the monthly face-to-face visits, not only 
were desired disease state outcomes achieved or maintained 
(A1c <7%, BP <140/80, etc.), but trusting and caring 
relationships developed between the resident and pharmacist. 
The community pharmacists were able to relay patient 
concerns to the provider and address patient health-related 
issues that may never have been brought to the provider’s 
attention. Each resident needed to be capable of self-
administering all medications, which proved to be difficult with 
complex medication regimens or technique administration 
challenges. Residents would share or be prompted to share if 
they were experiencing challenges with medication 
administration such as having to take large doses of 
medication at any given administration time or experiencing 
an adverse effect such as an antidepressant causing daytime 
drowsiness. 
 
Individual Patient Success Stories 
One study participant was managed for warfarin 
anticoagulation therapy. She agreed to participate in the study 
with two months remaining in the data collection phase. The 
researchers were only able to actively manage her warfarin 
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therapy in the last month of the study due to an unplanned 
visit to the emergency room in the second-to-last month of 
data collection. Her INR was evaluated using the CoaguChek®, 
a point-of-care testing device. The patient said she was thrilled 
the results were available within seconds and that it took a 
finger prick instead of a venous puncture. 
 
A study participant who was cognitively difficult to reach, but 
had an outstanding outcome was a resident of Hickory Grove. 
He managed his own medications and would only ask for 
assistance when calling in a refill. He stopped taking his 
levothyroxine because he believed the iodine in his 
multivitamin was doing the same job. His doctor gradually kept 
increasing his levothyroxine dose as his Thyroid Stimulating 
Hormone (TSH) continued to rise. Upon noticing the uptrend 
and realizing the levothyroxine had not been refilled since the 
last dose increase, the pharmacist had a conversation with the 
resident about adherence. It was at this time the misbelief 
about the iodine was discovered. After speaking with the 
resident about how levothyroxine works and why it is 
important to take every day, he agreed to allow the pharmacy 
to set up his medications in the compliance packaging. His next 
laboratory tests after this intervention yielded a TSH level 
within normal limits.  
 
Several of the residents stated they appreciated knowing 
someone else cared about them and their health. On-site 
nursing staff was not present to administer medications and 
the universal workers are not trained to handle medication. 
The community pharmacists had a two-fold impact on the 
health of the residents. They were able to provide disease 
state management services utilizing the protocols outlined in 
the CPAs as evidenced by the identification and resolution of 
drug therapy problems. The community pharmacists were also 
able to provide a level of emotional support that allowed the 
resident to feel like an engaged participant in his or her own 
health care.  
 
Improved Communication 
Improved quality of communication with the nursing staff at 
Hancock Village was a beneficial outcome of the study. As a 
trusting work relationship developed between the nursing 
staff and community pharmacists, the nursing staff began 
sharing criticisms and feedback of the medication dispensing 
processes and the community pharmacists were able to 
provide solutions for improved nursing workflow. This was 
primarily achieved through consistent telephone calls, emails, 
faxes, and sharing electronic access to Nauvoo Pharmacy’s 
packaging software with the nursing staff. Granting 
community pharmacists access to health system electronic 
medical records was considered an accomplishment by the 
research team and Nauvoo Pharmacy was able to reciprocate 
electronic access for the nursing staff at Hancock Village.  
 
 
 
Methods of Feasibility and Sustainability 
Although a sustainable payment model was not implemented 
during the duration of the study, potential methods of 
financial sustainability were recognized. The first method was 
to approach the health system with the idea of hiring the 
community pharmacist as an employee of the facility.  This 
implies every resident would receive services provided by the 
community pharmacist and the pharmacist would be available 
to meet other needs the facility may have. The proposed cost 
of the pharmacist would be included in each resident’s 
monthly housing expense and divided equally. This method 
seems to be the most attainable and simplistic in the short 
term because it does not involve figuring out how to bill for a 
pharmacist’s clinical services through the health system’s 
billing software. This is a challenge because pharmacists do not 
have independent provider status and most billing systems do 
not have an existing avenue to bill for pharmacist’s services.  
 
Including a clinically focused pharmacist on the facility 
treatment team can be of economical benefit to the facility. 
There are no other assisted living or supportive living facilities 
within a 50-mile radius that utilize the service of a clinical 
pharmacist (2017). Having a pharmacist involved in medication 
therapy management would be a way to differentiate the 
facility from others in order to achieve a higher or to-capacity 
occupancy rate. Conceptually, it is also anticipated that with 
the increased clinical pharmacist oversight, the resident would 
require fewer unplanned visits to the doctor’s office and fewer 
emergency room visits. More medically stable residents may 
require fewer resources and care from staff, and the facility 
may experience less turnover of residents to skilled nursing 
facilities.  
 
Another potential source of financial sustainability was billing 
for medication management services using incident-to billing 
codes through the local health system affiliated with Hancock 
Village Senior Services and providing the health system with a 
portion of the reimbursement. This method was not realized 
yet due to logistical and regulatory challenges associated with 
creating an avenue to bill for pharmacist services.  
 
Another method considered for obtaining financial 
sustainability was joining the Illinois Community Pharmacy 
Enhanced Network (I-CPEN) with support from the national 
Community Pharmacy Enhanced Service Network (CPESN 
USA). As defined by CPESN USA, “pharmacies providing 
Enhanced Services that transcend conventional requirements 
of an outpatient pharmacy program contract and focus on 
improving clinical and global patient outcomes.”12 The vision 
of I-CPEN is a network of community-focused pharmacies 
around the state that provide an elevated set of 
pharmaceutical care services to patients in collaboration with 
healthcare providers, health systems, Accountable Care 
Organizations (ACO), payers and pharmaceutical industry via a 
single contracting entity to document and achieve improved 
health outcomes.12 At the conclusion of the study, I-CPEN was 
Case Study COMMUNITY ENGAGEMENT 
 
http://z.umn.edu/INNOVATIONS                        2019, Vol. 10, No. 4, Article 13                       INNOVATIONS in pharmacy 
                                                                             DOI: https://doi.org/10.24926/iip.v10i4.1371 
6 
 
just laying groundwork to establish the foundation of the 
network. This is a promising alliance moving forward as the 
developed network and high-performing community 
pharmacies unite together.  
 
Processes for Best Practice 
Through the course of the data collection period, a best 
practice model for a community pharmacist providing services 
to residents residing in an assisted living and supportive living 
setting was identified. [Appendix B] An ever-improving system 
was developed and outlined for medication packaging and 
delivery, communication pathways to the providers and 
licensed nursing staff, and efficient workflow processes for the 
pharmacist to complete tasks.  The care model emphasizes the 
importance of establishing mutually respected working 
relationships between the pharmacists, providers, facility 
administers and staff before the service begins. Outlining a 
quality assurance standard to continually improve workflow, 
provide clinical documentation, ensure sustainability, and 
demonstrate accountability illustrates the value a pharmacist-
initiated service can provide to the interprofessional care 
team. 
 
Discussion 
Challenges 
There were several challenges to initiating clinically focused 
pharmacist services at Hancock Village. At the time of study 
initiation, Nauvoo Pharmacy was not providing medications 
for the residents of Hancock Village. Study participants had to 
have their medication dispensing transferred to Nauvoo 
Pharmacy, which took varying amounts of time and 
organization including obtaining new or transferred 
prescriptions and completing a comprehensive reconciled 
medication list. The decision to have Nauvoo Pharmacy 
exclusively fill the study participants’ medications provided 
control in communication and medication management rather 
than working as a third party in-between the dispensing 
pharmacy and facility. Many of the residents were hesitant of 
this change due to the fear of the unknown that comes along 
with change or because of hometown loyalty to the current 
dispensing pharmacy. The prior dispensing pharmacy made 
some efforts to retain the residents, which also contributed to 
this hesitancy. Some residents took several months to decide 
to participate in the study. In fact, 9 of the 15 study 
participants only decided to participate gradually over the last 
4 months of the data collection phase.  
  
Another challenge was working with prescribers who were not 
familiar with working with pharmacists as medication therapy 
managers. The lack of collaboration resulted in a significant 
delay in reaching a desired therapeutic outcome in at least one 
patient.  
 
The physician champion and Hancock Village medical director 
left the area midway through the data collection period. This 
resulted in a wider gap between the supportive physicians and 
resistant nurse practitioners making it difficult to continue to 
recruit study participants.  
 
During the study period, the local health system also began 
transitioning to a new health information system that affected 
the connected physicians’ offices and the hospital where many 
of the residents of Hancock Village received the majority of 
their care. Although supportive conversations to facilitate 
project progress with administrators occurred, getting follow-
through from them was difficult due to a number of changes 
within the health system. 
 
A great deal of education was necessary to get the facility 
nursing staff to facilitate an effective working relationship with 
Nauvoo Pharmacy. The amount of education needed was 
underestimated in the beginning of the project. The study 
required establishing more effective communication methods, 
new medication dispensing processes providing education to 
the nursing staff, and training the nursing staff on the scope of 
services and procedures to deliver accepted services. As a 
result of the study, improved relationships with the facility 
nursing staff were evident from an increase in volume of 
communication, directed medication-related questions, and a 
willingness to provide constructive feedback. The improved 
communication also made the process of procuring a 
reconciled medication list easier and less time consuming. This 
enhanced working relationship with nursing was made 
possible by keeping them consistently and thoroughly 
informed and following through with tasks as soon as possible. 
 
Another challenge was inconsistent timing and availability of 
both the clinical community pharmacist and licensed nursing 
staff at the facilities due to ever-changing schedules. It took 
rearranging schedules and consistent, prospective 
communication primarily via email to find available days and 
consecutive hours to coordinate meeting in person with 
nursing staff. 
 
Recruitment for project participation proved to be challenging. 
This effort was underestimated, in the beginning, due to the 
involved process of identifying who was the decision maker: 
the resident, family member, or other named resident 
representative. One-on-one meetings with the resident or 
resident’s family/power of attorney proved to be the most 
effective form of recruitment. Moving forward, this challenge 
could be circumvented with clinical pharmacist services 
included in the facility’s services available to all residents. 
 
Limitations 
The small sample size of 15 residents was a limitation. Having 
a small sample size may mean that the results of the study may 
not represent the effects if the study was performed in a larger 
population or a population that is more socioeconomically 
diverse.  Another limitation resulting from the small sample 
size was limitation to a case study design instead of a full 
quantitative analysis. Reasons for the small sample size may 
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have been the recruitment strategy, attitude of resistance to 
change, or incomplete understanding of what benefits might 
have been realized from participation. The reluctance of nurse 
practitioners to accept collaboration with the community 
pharmacists may have kept residents from being willing 
participants in the study. Nurse practitioners from the local 
health care system provided the majority of the primary health 
care for the residents of Hancock Village. A possible way to 
address this limitation in the future could be to focus on 
establishing a better working relationship with providers 
during the project initiation phase.  
 
Conclusion 
Community pharmacists actively managing medications 
through collaborative practice agreements can positively 
impact supportive living and assisted living memory care 
residents’ overall quality of life, provide clinical value to rural 
providers, and reduce healthcare costs. Pharmacists can 
provide clinical assessment, medication and disease state 
education, along with effective communication to optimize 
medication management and utilization. Incorporating a 
community pharmacist as a member of the rural healthcare 
team for residents in a supportive living or assisted living 
facility is feasible. Securing a sustainable financial model in any 
start-up pharmacy service is still a challenge due to 
pharmacists not having provider status to bill independently 
for clinical services. Further areas of study to expand the utility 
of this geriatric-focused medication management process 
could extend to the aging population living independently in 
their own homes. 
 
The combined force and dedication of active community 
pharmacists providing enhanced services in managing 
medication therapy for all patients would give depth of 
objective data and an additional perspective to the 
interprofessional healthcare team to help patients achieve 
health-related goals.  
 
The authors are willing to share collaborative practice 
agreements and standing orders with anyone interested in 
obtaining copies. 
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Appendix A 
Description of Pharmacist-Initiated Interventions 
Drug Therapy 
Problem (DTP) 
Total DTPs 
Identified 
Accepted (A)/ 
Rejected (R) 
Description of DTP 
Unnecessary Drug 
Therapy 
4 4/0 1. Discontinued therapeutic duplication (ranitidine and famotidine) - 
A 
2. Removed Mucinex DM (tablets and liquid) q6hr prn and changed 
to Mucinex BID - A 
3. Removed milk of magnesia daily prn – had never used and has 
polyethylene glycol daily prn that she prefers to use – A 
4. Removed multiple vitamin duplications and kept patient on a 
single multivitamin for women - A 
Wrong Drug 4 3/1 1. Changed Namenda XR 28mg to Namenda 10mg BID for cost 
savings - A 
2. Changed daily Vitamin D 1,000 units to once weekly Vitamin 
10,000 units to minimize pill burden - A 
3. Patient on melatonin with no sleep improvement – 
recommended to change to low-dose mirtazapine – R  
4. Patient fell while on liquid Benadryl and no sleep improvement – 
recommended to change to low-dose mirtazapine - A 
Dose too low 4 3/1 1. Increased lisinopril from 5mg to 10mg - A 
2. Increased lisinopril from 10mg to 20mg - A 
3. Increased lisinopril from 20mg to 40mg - A 
4. Recommended increase lisinopril from 40mg to 40mg BID - R 
Dose too high 1 1/0 1. Reduced risperidone 1mg TID to risperidone 0.5mg    TID due to 
falls/confusion/ataxia - A 
Adverse Drug 
Reaction 
3 3/0 1. Changed administration time of citalopram to HS due to daytime 
drowsiness - A 
2. Changed administration time of famotidine to HS due to potential 
dementia-like side effects and reduced renal function - A 
3. Changed Actos to Januvia – patient experiencing moderately 
significant lower extremity edema (likely due to comorbidity 
heart failure – patient on high dose furosemide) - A 
Inappropriate 
adherence 
4 4/0 1. Patient managing own medications – stopped taking 
levothyroxine because he believes the iodine in his multivitamin 
is doing the same job as levothyroxine. Educated patient about 
mechanism of action and the benefits of taking as prescribed. Lab 
was within normal limits at next lab draw - A 
2. Patient prescribed to take Lantus BID – needs prompting and 
administration assistance from nursing staff, so HS dose is 
regularly missed (no nursing staff at HS) Changed BID dosing to 
once daily dosing - A 
3. Patient managing own medications – stopped atorvastatin on 
own because LDL was at goal and patient didn’t understand that 
this was intended to be a long-term medication. Educated patient 
– A 
4. Patient with uncontrolled blood sugars on Lantus BID – has 
cognitive impairment and often misses evening injection – 
recommended once daily Lantus (43 units in the morning) - A 
 
Needs additional 
drug therapy 
3 1/2 1. Initiated lisinopril due to resistant hypertension and diabetes - A 
2. Recommended missing statin therapy on a diabetic patient - R 
3. Recommended initiating fish oil for elevated triglyceride level - R 
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Appendix B 
Assisted Living Memory Care and Supportive Living Best Practice Model 
 
Outline of a clinically focused pharmacist service to provide medication management as an included service to ALL residents living in 
Hancock Village 
 
1) Establish mutually respected relationships with licensed nursing staff and administrators at facilities and share 
characteristics of clinical pharmacist service 
 
2) Establish mutually respected relationships with area primary care providers (provider in-service meetings, one-on-one 
meetings with providers, etc.) and share characteristics of clinical pharmacist service 
 
3) Create collaborative practice agreements (CPAs) in accordance with current national guidelines for each intended disease 
state as established from evidence-based medicine. Get CPAs signed by participating primary care providers 
 
4) Provide education to residents on a one-on-one basis upon admission – have resident sign acknowledgement that this 
information has been reviewed and what he or she should expect 
 
5) Admit resident 
a. Procure medication list from family and doctor’s office 
b. Inspect medication vials when feasible (confirm medication strength, directions, prescribing doctor, and any other 
visual clues) 
c. Complete medication reconciliation before medications lists are sent to pharmacy for dispensing (this cleans up 
the process moving forward) 
d. Complete an initial chart review to familiarize with past medical history (History & Physical), more recent 
laboratory results, allergies, current co-morbidities, and main health concerns 
 
6) Meet with resident for assessment and evaluation of his or her current medication utilization (Initial meeting up to 45 
minutes, and follow-up meetings 20-30 minutes) 
a. Formulate a medication management care plan  
b. Review plan with resident, licensed nursing staff, and primary provider 
c. Send medication therapy management plan to dispensing pharmacy 
 
7) Follow-up – monthly clinical pharmacist chart review to assess for changes in health status and medications and face-to-
face meeting with resident.  In addition, quarterly face-to-face pharmacist and nursing physical assessments with 
resident/lab review/discussion would be coordinated with licensed nursing staff 
a. Make further recommendations to medication management care plan as warranted 
b. Update medication management care plan and inform nursing staff, providers, and dispensing pharmacy  
i. Updates will be relayed to provider via electronic record  
 
8) Continue the cycle  
 
Goals/Objectives 
1) Demonstrate need, feasibility and financial sustainability of clinical pharmacist service to manage disease states in partnership 
with rural primary care providers 
2) Create process for best practice in the supportive living and assisted living setting to be used as a model for other like facilities 
3) Evaluate the impact of active pharmacist participation on patient care  
a. Track the number of doctor/emergency room visits 
b. Track the number of acute hospital admissions/readmissions in local health system 
c. Track turnover of resident apartments/empty apartments 
d. Track ability of pharmacist to recognize early changes in health status and interventions made to prevent further 
deterioration 
e. Track interventions made to maximize correct medication utilization (administration and technique) 
f. Create opportunity for residents or resident representatives to provide comments on pharmacist services and evaluate 
value of feedback 
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System Analysis/Quality Assurance Program 
The Quality Assurance team will consist of the pharmacist, facility administrator, lead clinical nurse, medical director, and facility 
staff nurses. The team will meet at least annually and more often as needed for one hour. 
1) Compile pharmacist interventions (identify proposed drug therapy problem recommendations and accepted vs. declined 
and the trend thereof) 
2) Evaluate therapeutic response secondary to medication adjustment 
3) Make process improvement recommendations as identified to outline best practice model (based on the results of the 
quality assurance meetings the process will be modified to meet the needs of the residents) 
4) Ensure sustainability – track expenses (pharmacist time vs. revenue), be diligent in finding new methods to stay financially 
current 
 
 
 
 
 
 
 
